MKI67 and neoplasm: For SUVmax (HR 1.03, p = 0.003), Ki‐67 dichotomised (HR 2.56, p = 0.008), tumour differentiation (HR 2.68 p = 0.008), platelets (HR 2.44, p = 0.006) and PS dichotomised (HR 2.48, p = 0.006) there was strong evidence that these were prognostic for OS with a good clinical effect size (HR).